Spinal Muscular Atrophy Type 3
Rare Disease·MeSH: Spinal Muscular Atrophies of Childhood
Prevalence
1.5 / 100K
Incidence
1.0 / 100K/yr
0 drugs in development·0 companies·3 clinical trials
Frequently asked questions
How many clinical trials target Spinal Muscular Atrophy Type 3?
There are 3 clinical trials targeting Spinal Muscular Atrophy Type 3 tracked by BioSniper.
What is the prevalence of Spinal Muscular Atrophy Type 3?
The estimated prevalence of Spinal Muscular Atrophy Type 3 is approximately 1.5 per 100,000 population.
Deep-dive into Spinal Muscular Atrophy Type 3
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis